Gastro-oesophageal Reflux Disease Trial, Recruiting (NCT07267117)

Gastro-oesophageal Reflux Disease Trial, Recruiting NCT07267117 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Gastro-oesophageal Reflux Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07267117 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gord

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are at least 18 years old
People who are willing and able to give their consent to take part in the study
People who have been diagnosed with heart valve disease through an ultrasound of the heart (echocardiography), and whose results meet specific measurements showing at least moderate leaking or narrowing of one of the four heart valves — this includes the aortic valve, mitral valve, tricuspid valve, or pulmonary valve (confirm with trial site for exact measurement thresholds)

Who may not be able to join:

People who are not willing to be registered in the study or to attend follow-up appointments
People who are unable to take part in information collection or follow-up visits due to a mental health condition or other reasons that affect their ability to cooperate
People who have a non-heart-related illness (such as cancer, liver disease, kidney disease, or advanced lung disease) that means their life expectancy is less than 12 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07267117

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase: Not Applicable

Status: Recruiting

Condition: Gastro-oesophageal Reflux Disease

More information: https://clinicaltrials.gov/study/NCT07267117

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are at least 18 years old
People who are willing and able to give their consent to take part in the study
People who have been diagnosed with heart valve disease through an ultrasound of the heart (echocardiography), and whose results meet specific measurements showing at least moderate leaking or narrowing of one of the four heart valves — this includes the aortic valve, mitral valve, tricuspid valve, or pulmonary valve (confirm with trial site for exact measurement thresholds)

Who may not be able to join:

People who are not willing to be registered in the study or to attend follow-up appointments
People who are unable to take part in information collection or follow-up visits due to a mental health condition or other reasons that affect their ability to cooperate
People who have a non-heart-related illness (such as cancer, liver disease, kidney disease, or advanced lung disease) that means their life expectancy is less than 12 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Registry

ClinicalTrials.gov

Start date

1 June 2025

Est. completion

31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

All cause mortality; Heart valve replacement or repair; Stroke; Re-hospitalization related to cardiovascular disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov